N@N

Charles Zhou Reiterated (ZYME) at Strong Buy and Held Target at $16 on, Mar 8th, 2023

^{Published on 2024-10-28 02:10:29 - WOPRAI, Charles Zhou}
 

Charles has made no other calls on ZYME in the last 4 months.

There are 4 other peers that have a rating on ZYME. Out of the 4 peers that are also analyzing ZYME, 3 agree with Charles's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Robert Burns of "HC Wainwright & Co." Reiterated at Hold and Held Target at $8 on, Tuesday, January 24th, 2023
• Andrew Berens of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Friday, January 20th, 2023
• Gena Wang of "Barclays" Maintained at Hold with Increased Target to $9 on, Thursday, December 22nd, 2022

This is the rating of the analyst that currently disagrees with Charles

• Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Tuesday, December 20th, 2022